CLCN7 Polyclonal Antibody

CLCN7 Polyclonal Antibody

Catalog Number:
A001508072RED
Mfr. No.:
RD252548A
Price:
$253
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Gene Accession: BC012737

          Please contact us at for specific academic pricing.

          Background

          The product of this gene belongs to the CLC chloride channel family of proteins. Chloride channels play important roles in the plasma membrane and in intracellular organelles. This gene encodes chloride channel 7. Defects in this gene are the cause of osteopetrosis autosomal recessive type 4 (OPTB4), also called infantile malignant osteopetrosis type 2 as well as the cause of autosomal dominant osteopetrosis type 2 (OPTA2), also called autosomal dominant Albers-Schonberg disease or marble disease autosoml dominant. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. OPTA2 is the most common form of osteopetrosis, occurring in adolescence or adulthood.

      • Properties
        • Host
          rabbit
          Antibody Type
          polyclonal
          Isotype
          IgG
          Reactivity
          human; mouse; rat
          Immunogen
          Fusion protein of human CLCN7
          Purification
          Antigen affinity purification
          Conjugate
          Unconjugated
          Formulation
          PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
          Storage
          Store at -20°C. Avoid freeze-thaw cycles.
          Concentration
          1.56 mg/mL
          Antigen
          Chloride channel protein 7, CLC 7, ClC-7, ClC7, CLCN7, CLCN7, FLJ26686, FLJ39644, FLJ46423, H(+)/Cl(-) exchange transporter 7, OPTA2, OPTB4 (UniProt:P51798)

          * For reference only.

      • Applications
        • Application
          IHC; ELISA
        • Application Dilutions
          IHC 1:50-1:100
          ELISA 1:5000-1:10000

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.